Talk:Α-Aminoadipate pathway
Latest comment: 8 months ago by KormiSK in topic Split proposal
![]() | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
|
![]() | The contents of the Alpha-Aminoadipic acid page were merged into Α-Aminoadipate pathway on 7 September 2016. For the contribution history and old versions of the redirected page, please see its history; for the discussion at that location, see its talk page. |
Diabetes?
editThe introductory comment "In the eukaryotes, this pathway is unique to the higher fungi (containing chitin in their cell walls) and the euglenids" doesn't fit very well with the reference to predicting diabetes (in humans). — Preceding unsigned comment added by Tslumley (talk • contribs) 19:33, 29 January 2020 (UTC)
Split proposal
editKingisNitro proposes that this article be split into Α-Aminoadipate pathway and Α-Aminoadipic acid, writing "I am suggesting split because these are two different pages and I really don't see a reason to only mention them together". Note that these articles used to be separate until they were merged in 2013 (see Talk:Alpha-Aminoadipic_acid). Mdewman6 (talk) 01:04, 4 March 2022 (UTC)
- Then maybe the solution should be to expand them instead of merging them. And if they are merged, I would personally move this to Α-Aminoadipic acid instead, as that is what the pathway is named by, not the other way around. KingisNitro (talk) 10:33, 4 March 2022 (UTC)
- Absolutely more content could be added about the compound and/or the pathway. I think part of the ratioale for the merge was there wasn't really enough content at the time to justify separate articles. I think you may have a point about the name. In that case, I would suggest a new requested move discussion to consider switching the names. Mdewman6 (talk) 01:35, 5 March 2022 (UTC)
- Been a while but I've split the page into this page and α-aminoadipic acid. KormiSK (talk) 02:08, 26 December 2023 (UTC)
- Absolutely more content could be added about the compound and/or the pathway. I think part of the ratioale for the merge was there wasn't really enough content at the time to justify separate articles. I think you may have a point about the name. In that case, I would suggest a new requested move discussion to consider switching the names. Mdewman6 (talk) 01:35, 5 March 2022 (UTC)